Retrieved on Jan 5, 2026 from Kim, J
That means it isn't only your appetite becoming quieter, your taste buds may be turning down the volume too
The search string was constructed as follows: (Semaglutide [MeSH] OR Ozempic) AND (Thyroid Neoplasms [MeSH] OR thyroid cancer OR thyroid C-cell tumors OR medullary thyroid carcinoma) AND (Glucagon-Like Peptide 1 Receptor Agonists [MeSH] OR carcinogenic risk OR endocrine neoplasms) AND (Carcinogenesis [MeSH] OR antidiabetic agents and cancer risk OR safety of GLP-1 OR semaglutide adverse effects OR semaglutide adverse reactions OR semaglutide complications OR neoplastic risk) AND (Pharmacovigilance [MeSH] OR Drug-Related Side Effects and Adverse Reactions [MeSH])
Data collection encompassed demographics, fibrosis stage, MELD-Na scores, BMI, medication usage (statins, GLP-1 agonists), complete blood count, comprehensive metabolic panel, A1c, cholesterol levels, INR, and AFP at both evaluation points